Background
Methods
Patients
Treatment
Outcomes assessments
Statistical analysis
Results
Baseline characteristics
Characteristics of mothers | Telbivudine group (N = 139) | Control group (N = 102) | P value |
---|---|---|---|
Age, years, median (range) | 26 (20–43) | 26 (18–42) | 0.061 |
Prior pregnancy, median (range) | 1 (1–4) | 1 (1–4) | 0.224 |
HBV DNA levels, log10 IU/mL, median (range) | 7.73 (6.04~9.30) | 7.72 (6.03~9.00) | 0.858 |
HBV DNA levels > 108 IU/mL, n (%) | 60 (43.2%) | 45 (44.1%) | 0.883 |
HBV DNA levels 107–108 IU/mL, n (%) | 62 (44.6%) | 36 (35.3%) | 0.184 |
ALT level, U/L, median (range) | 117 (56–1166) | 164 (53–1025) | 0.867 |
AST level, U/L, median (range) | 112 (32–1061) | 101 (35–539) | 0.301 |
Elevated AST levels, n (%) | 136 (97.8%) | 101 (99.0%) | 0.640 |
TBIL, μmol/L, median (range) | 11 (4–125) | 11 (3–96) | 0.911 |
HBeAg positive, n (%) | 126 (90.6%) | 91 (89.2%) | 0.714 |
Efficacy of telbivudine treatment
Telbivudine (N = 139) | Control (N = 102) | P value | |
---|---|---|---|
HBV DNA, log10 IU/mL, median (range) | |||
Week 2 | 5.51 (3.04–8.06) | 7.74 (6.03–9.00) | < 0.001 |
Week 4 | 4.12 (2.70–7.43) | 7.70 (6.03–9.00) | < 0.001 |
Week 8 | 3.20 (2.70–6.76) | 7.74 (6.03–9.00) | < 0.001 |
At delivery | 2.82 (2.70–6.45) | 7.72 (5.32–9.00) | < 0.001 |
ALT levels at delivery, U/L, median (range) | 28 (11–238) | 47 (8–217) | < 0.001 |
Normalization rate of ALT, n (%) | 105 (75.5%) | 52 (51%) | < 0.001 |
AST levels at delivery, U/L, median (range) | 27 (11–141) | 39 (17–144) | < 0.001 |
Normalization rate of AST, n (%) | 112 (80.6%) | 55 (53.9%) | < 0.001 |
TBIL levels at delivery, U/L, median (range) | 1.1 (9.8–36.0) | 9.5 (3.8–48.6) | 0.459 |
Normalization rate of TBIL, n (%) | 137 (98.6%) | 100 (98.0%) | 1.000 |
HBeAg positive at delivery, n (%) | 108 (77.7%) | 91 (89.2%) | 0.025 |
Safety of telbivudine treatment
Telbivudine | Control | P value | |
---|---|---|---|
CK Elevation of mother, n (%) | 7 (5%) | 0 (0%) | 0.022 |
Malformation induced labor, n | 1 | 1 | 1.000 |
Abortion, n | 1 | 2 | 0.575 |
Premature labor, n | 3 | 2 | 1.000 |
Congenital diseases, n | 1 | 1 | 1.000 |